GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogen Inc (BUE:BIIB) » Definitions » Total Tax Payable

Biogen (BUE:BIIB) Total Tax Payable : ARS667,446 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Biogen Total Tax Payable?

Biogen's Total Tax Payable for the quarter that ended in Mar. 2025 was ARS667,446 Mil.

Biogen's quarterly Total Tax Payable increased from Sep. 2024 (ARS474,395 Mil) to Dec. 2024 (ARS553,783 Mil) and increased from Dec. 2024 (ARS553,783 Mil) to Mar. 2025 (ARS667,446 Mil).

Biogen's annual Total Tax Payable increased from Dec. 2022 (ARS43,572 Mil) to Dec. 2023 (ARS92,921 Mil) and increased from Dec. 2023 (ARS92,921 Mil) to Dec. 2024 (ARS553,783 Mil).

Biogen Total Tax Payable Historical Data

The historical data trend for Biogen's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogen Total Tax Payable Chart

Biogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,555.96 17,642.95 43,572.23 92,921.40 553,783.01

Biogen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 194,786.00 252,172.80 474,394.53 553,783.01 667,445.73

Biogen Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Biogen Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Biogen's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Biogen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biogen Inc (BUE:BIIB) » Definitions » Total Tax Payable
Comparable Companies
OGN AMRN MDCX SCLX MIRA LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN GILD PFE XPAR:SAN BMY TSE:4519 LSE:GSK
Traded in Other Exchanges
BIIB:USA BIIB:Mexico 1BIIB:Italy 0R1B:UK IDP:Germany BIIB:Chile BIIB34:Brazil BIIB:Austria
Address
225 Binney Street, Cambridge, MA, USA, 02142
Website
https://www.biogen.com
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products include Spinraza (SMA, with partner Ionis), Leqembi (Alzheimers, with partner Eisai), Skyclarys (Friedreich's Ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (ALS, Ionis). Biogen has several drug candidates in phase 3 trials in neurology, immunology, and rare diseases.